Aryl Hydrocarbon Receptor as a Drug Target
Search documents
Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Target and EQ504 Program in Immune-Mediated Diseases - Slideshow (NASDAQ:EQ) 2025-11-09
Seeking Alphaยท 2025-11-09 23:35
Group 1 - The article does not provide any specific content related to a company or industry [1]
